L'acido azelaico nella terapia dell'acne.

Translated title of the contribution: Azelaic acid in the treatment of acne

M. Nazzaro-Porro, S. Passi, M. Picardo, A. S. Breathnach, G. Zina

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This review is an update of the literature accumulated over the past 6 years following the original observation that topically applied azelaic acid, a non-toxic C9 dicarboxylic acid, has a beneficial therapeutic effect on acne vulgaris. These studies have shown that azelaic acid has a modulating influence on the process of keratinization, and that it acts as a keratolytic and anti-comedogenic agent. There is evidence that it inhibits mitochondrial and microsomal oxido-reductases, including 5-alpha-reductase, and that it may interfere with the process of sebogenesis. It has a spectrum of antimicrobial activity, both in vitro and in vivo, against aerobic microorganisms and is effective against the anaerobic Propionibacterium acnes. Extensive multi-centre clinical trials have established that topical azelaic acid (a 20% cream) is an effective treatment for all types of acne. It compares well with other agents, such as topical tretinoin or benzoyl-peroxide, or oral tetracycline. It is non-irritant, and does not give rise to allergic or photo-toxic reactions. Its use is not associated with teratogenicity, possible endocrine unbalance, or the disadvantages of antibiotic treatment. It can be applied for long periods, in recurrences, and as maintenance "spot" therapy against individual lesions.

Original languageItalian
Pages (from-to)175-184
Number of pages10
JournalGiornale Italiano di Dermatologia e Venereologia
Volume124
Issue number4
Publication statusPublished - Apr 1989

Fingerprint

Acne Vulgaris
Cholestenone 5 alpha-Reductase
Benzoyl Peroxide
Propionibacterium acnes
Dicarboxylic Acids
Poisons
Therapeutic Uses
Tretinoin
Tetracycline
Oxidoreductases
Maintenance
Clinical Trials
Anti-Bacterial Agents
Recurrence
azelaic acid
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Nazzaro-Porro, M., Passi, S., Picardo, M., Breathnach, A. S., & Zina, G. (1989). L'acido azelaico nella terapia dell'acne. Giornale Italiano di Dermatologia e Venereologia, 124(4), 175-184.

L'acido azelaico nella terapia dell'acne. / Nazzaro-Porro, M.; Passi, S.; Picardo, M.; Breathnach, A. S.; Zina, G.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 124, No. 4, 04.1989, p. 175-184.

Research output: Contribution to journalArticle

Nazzaro-Porro, M, Passi, S, Picardo, M, Breathnach, AS & Zina, G 1989, 'L'acido azelaico nella terapia dell'acne.', Giornale Italiano di Dermatologia e Venereologia, vol. 124, no. 4, pp. 175-184.
Nazzaro-Porro M, Passi S, Picardo M, Breathnach AS, Zina G. L'acido azelaico nella terapia dell'acne. Giornale Italiano di Dermatologia e Venereologia. 1989 Apr;124(4):175-184.
Nazzaro-Porro, M. ; Passi, S. ; Picardo, M. ; Breathnach, A. S. ; Zina, G. / L'acido azelaico nella terapia dell'acne. In: Giornale Italiano di Dermatologia e Venereologia. 1989 ; Vol. 124, No. 4. pp. 175-184.
@article{f718369352cb4a00ad22ba5687c60cb6,
title = "L'acido azelaico nella terapia dell'acne.",
abstract = "This review is an update of the literature accumulated over the past 6 years following the original observation that topically applied azelaic acid, a non-toxic C9 dicarboxylic acid, has a beneficial therapeutic effect on acne vulgaris. These studies have shown that azelaic acid has a modulating influence on the process of keratinization, and that it acts as a keratolytic and anti-comedogenic agent. There is evidence that it inhibits mitochondrial and microsomal oxido-reductases, including 5-alpha-reductase, and that it may interfere with the process of sebogenesis. It has a spectrum of antimicrobial activity, both in vitro and in vivo, against aerobic microorganisms and is effective against the anaerobic Propionibacterium acnes. Extensive multi-centre clinical trials have established that topical azelaic acid (a 20{\%} cream) is an effective treatment for all types of acne. It compares well with other agents, such as topical tretinoin or benzoyl-peroxide, or oral tetracycline. It is non-irritant, and does not give rise to allergic or photo-toxic reactions. Its use is not associated with teratogenicity, possible endocrine unbalance, or the disadvantages of antibiotic treatment. It can be applied for long periods, in recurrences, and as maintenance {"}spot{"} therapy against individual lesions.",
author = "M. Nazzaro-Porro and S. Passi and M. Picardo and Breathnach, {A. S.} and G. Zina",
year = "1989",
month = "4",
language = "Italian",
volume = "124",
pages = "175--184",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - L'acido azelaico nella terapia dell'acne.

AU - Nazzaro-Porro, M.

AU - Passi, S.

AU - Picardo, M.

AU - Breathnach, A. S.

AU - Zina, G.

PY - 1989/4

Y1 - 1989/4

N2 - This review is an update of the literature accumulated over the past 6 years following the original observation that topically applied azelaic acid, a non-toxic C9 dicarboxylic acid, has a beneficial therapeutic effect on acne vulgaris. These studies have shown that azelaic acid has a modulating influence on the process of keratinization, and that it acts as a keratolytic and anti-comedogenic agent. There is evidence that it inhibits mitochondrial and microsomal oxido-reductases, including 5-alpha-reductase, and that it may interfere with the process of sebogenesis. It has a spectrum of antimicrobial activity, both in vitro and in vivo, against aerobic microorganisms and is effective against the anaerobic Propionibacterium acnes. Extensive multi-centre clinical trials have established that topical azelaic acid (a 20% cream) is an effective treatment for all types of acne. It compares well with other agents, such as topical tretinoin or benzoyl-peroxide, or oral tetracycline. It is non-irritant, and does not give rise to allergic or photo-toxic reactions. Its use is not associated with teratogenicity, possible endocrine unbalance, or the disadvantages of antibiotic treatment. It can be applied for long periods, in recurrences, and as maintenance "spot" therapy against individual lesions.

AB - This review is an update of the literature accumulated over the past 6 years following the original observation that topically applied azelaic acid, a non-toxic C9 dicarboxylic acid, has a beneficial therapeutic effect on acne vulgaris. These studies have shown that azelaic acid has a modulating influence on the process of keratinization, and that it acts as a keratolytic and anti-comedogenic agent. There is evidence that it inhibits mitochondrial and microsomal oxido-reductases, including 5-alpha-reductase, and that it may interfere with the process of sebogenesis. It has a spectrum of antimicrobial activity, both in vitro and in vivo, against aerobic microorganisms and is effective against the anaerobic Propionibacterium acnes. Extensive multi-centre clinical trials have established that topical azelaic acid (a 20% cream) is an effective treatment for all types of acne. It compares well with other agents, such as topical tretinoin or benzoyl-peroxide, or oral tetracycline. It is non-irritant, and does not give rise to allergic or photo-toxic reactions. Its use is not associated with teratogenicity, possible endocrine unbalance, or the disadvantages of antibiotic treatment. It can be applied for long periods, in recurrences, and as maintenance "spot" therapy against individual lesions.

UR - http://www.scopus.com/inward/record.url?scp=0024472917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024472917&partnerID=8YFLogxK

M3 - Articolo

VL - 124

SP - 175

EP - 184

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 4

ER -